Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,470 | Dovepress* | 4,976+ | 631 | 5,607 | |
PubMed Central* | 494 | 151 | 645 | ||
Totals | 5,470 | 782 | 6,252 | ||
*Since 22 April 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar